Evoke plc (LON:EVOK – Get Free Report) fell 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
EVOK has been the topic of several recent research reports. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank decreased their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th.
View Our Latest Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, research analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 03/24 – 03/28
- Dividend Payout Ratio Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Buy P&G Now, Before It Sets A New All-Time High
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.